Midwestern communities like Hastings contend with high prescription drug prices alongside an 30.1% adult obesity rate and 8.5% adult diabetes rate. Mounjaro® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly. Weight Method offers a separate telehealth option: licensed Minnesota providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month and includes the provider evaluation, the medication, ongoing care, and home shipping to Hastings.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Hastings is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Hastings, MN. Weight Method offers compounded tirzepatide, prescribed by licensed providers, from $329/month with virtual consultations and direct-to-door shipping.
Tirzepatide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Eli Lilly developed Mounjaro® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2022. Weight Method is a separate program: licensed providers in Minnesota evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program for eligible Hastings, MN residents starts at $329/month.
Suburban life around Hastings comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Tirzepatide therapy addresses biology involved in weight regulation by reducing hunger signals, so Hastings area residents can break patterns that willpower alone cannot fix. Weight Method prescribes compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy, at $329/month, delivered to your door. Compounded Tirzepatide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Minnesota and start Mounjaro from $329/month.
Get Started NowFree consultation. No commitment.